ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,381,013, issued on Aug. 5, was assigned to GENENTECH INC. (South San Francisco, Calif.).
"Predicting tolerability in aggressive non-hodgkin lymphoma" was invented by Tina Geritz Nielsen (Basel, Switzerland), Joseph Nathaniel Paulson (South San Francisco, Calif.), Daniel Jay Schneider (Wynnewood, Pa.), Edward Jean Bataillard (Welwyn Garden City, Great Britain), Carl Wilson Harris III (South San Francisco, Calif.), Carsten Henneges (South San Francisco, Calif.) and Yoonha Choi (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods described herein improve outcomes of subjects with lymphoma. Subjects with lymphoma ma...